Sponsor Pipeline

Idorsia Pharmaceuticals Ltd. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
4
Active Trials
1
Recruiting
1
Phase 3
What Changed in the Last 30 Days
First PostedNew Trial FilingPhaseStatus
2026-08-13 NCT07762638 Post Trial Access to Lucerastat for Patients With Fabry Disease Who Participated in Study… Available
Active Trials by Phase
Phase 3
1
Phase 2
1
Not specified
2
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT03737214 A Study to Evaluate the Long-term Safety and Tolerability of Lucerastat in Adult Subjects… Fabry Disease Active, Not Recruiting
Phase 2
NCT07667569 A Study to Learn How Safe ACT-777991 is and How Well it Works in Adults With… Non-Segmental Vitiligo Not Yet Recruiting
Not specified
NCT06498128 Registry to Collect Information on Pregnancy, Neonatal, and Infant Outcomes in Pregnant… Insomnia Recruiting
NCT06393504 Database Study to Provide Information on Pregnancy and Infant Outcomes Among Women… Insomnia Disorder Active, Not Recruiting
Get alerts when Idorsia Pharmaceuticals Ltd.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free